Table 2.

Proportion among the 149 European IC specialists perceiving a high individual and collective risk to patients globally and by type of multidrug-resistant organisms

Footnotes:

Individual risk corresponds to the risk of poor clinical outcomes for infected/colonised patients; collective risk corresponds to the risk for contact patients to become colonised and the transmission to other patients. N represents the total number of case-vignettes scored

Colours relate to the percentage of participants selecting the item where red = 0% of selection, yellow = 50% and green = 100% of selection by participants

Abbreviations: IC Infection control, MRSA Methicillin resistant Staphylococcus aureus, ESBL-PE Extended spectrum betalactamase producing Enterobacteriaceae, CPE Carbapenemase producing Enterobacteriaceae, KPC Klebsiella pneumoniae carbapenemase, CR-Ab Carbapenem-resistant Acinetaobacter baumannii, VRE Vancomycin resistant Enterococci, CR-Pa Carbapenemase Resistant-Pseudomonas aeruginosa